The BIOMED-2 Concerted Action BMH4-CT98-3936 on 'Polymerase chain reaction (PCR)-based clonality studies for early diagnosis of lymphoproliferative disorders' developed standardized PCR protocols for detection of immunoglobulin (Ig) and T-cell receptor (TCR) rearrangements, including TCR beta (TCRB). As no comparable TCRB PCR method pre-existed and only a limited number of samples was tested within the BIOMED-2 study, we initiated this study for further validation of the newly developed TCRB PCR approach by comparing PCR data with previously generated Southern blot (SB) data in a series of 66 immature (ALL) and 36 mature T-cell malignancies. In 91% of cases, concordant PCR and SB results were found. Discrepancies consisted of either failure to detect SB-detected TCRB rearrangements by PCR (6.5%) or detection of an additional non-SB defined rearrangement (2.5%). In 99% of cases (99/100), at least one clonal TCRB rearrangement was detected by PCR in the SB-positive cases. A predominance of complete Vb-Jb rearrangements was seen in TCRab þ T-cell malignancies and CD3-negative T-ALL (100 and 90%, respectively), whereas in TCRcd þ T-ALL, more incomplete Db-Jb TCRB rearrangements were detected (73%). Our results underline the reliability of this new TCRB PCR method and its strategic applicability in clonality diagnostics of lymphoproliferative disorders and MRD studies.
Introduction
During early T-cell development, T-cell receptor delta (TCRD) and TCR gamma (TCRG) rearrangements precede TCR beta (TCRB) rearrangements. 1, 2 Consequently, virtually all mature Tcell malignancies contain TCRB rearrangements, but also most immature T-cell malignancies, such as acute lymphoblastic leukemias (ALL), show rearranged TCRB genes. [3] [4] [5] The TCRB gene cluster contains 65 Vb gene segments (39-47 of which are qualified as functional) and two Db-Jb-Cb regions that each consist of one Db gene segment (TCRBD1 and TCRBD2) followed by a Jb cluster, which comprises six (TCRBJ1S1 to TCRBJ1S6) or seven (TCRBJ2S1 to TCRBJ2S7) segments, respectively, and a Cb gene segment (TCRBC1 and TCRBC2) (see Figure 1) . 2, [6] [7] [8] [9] [10] The process of rearranging the TCRB gene is generally initiated by Db-Jb joining, leading to an incomplete TCRB rearrangement. In a second rearrangement step, a Vb gene segment is added, resulting in a complete VbDb-Jb rearrangement. 11 Rarely, other types of incomplete rearrangements can be found, such as Vb-Db and Db-Db. Owing to the unique structure of the Db-Jb-Cb region with its two consecutive Db-Jb clusters, more than one rearrangement per allele may be detectable: when a Vb segment or the Db1 segment joins to a gene segment in the Jb 1 region, an independent, incomplete Db 2 -Jb 2 may still occur (see Figure 1 ). 2 Molecular analysis of TCR gene rearrangements including TCRB rearrangements is a useful tool for clonality diagnostics in suspect T-cell proliferations. Detection of TCRB rearrangements can also be of major interest for minimal residual disease (MRD) studies in lymphoproliferative disorders, because the extensive combinatorial repertoire and highly diverse junctional regions make TCRB rearrangements excellent and highly stable polymerase chain reaction (PCR) targets for MRD diagnostics. [12] [13] [14] TCRB rearrangements are not only detectable in most T-cell malignancies but have also been found in approximately 35% of precursor B-ALL. 3, 15, 16 Analysis of TCR gene rearrangements can be performed either by Southern blot (SB) analysis, which has long been the 'gold standard' for clonality assessment, or by PCR. As SB is a laborintensive and time-consuming method requiring high molecular weight DNA, the rapid and sensitive PCR technique is now broadly applied for clonality assessment. However, the extensive recombinatorial repertoire complicates the molecular analysis of TCRB rearrangements by PCR. Previously described TCRB PCR methods used highly degenerated consensus primers that limited the number of detectable rearrangements, [17] [18] [19] used multiple tubes (20) (21) (22) (23) (24) (25) with family-specific Vb and multiple Jb primers, 20, 21 or used RNA in RT-PCR with a single Cb primer to reduce the number of primers needed. 22 Within the BIOMED-2 Concerted Action BMH4-CT98-3936 'PCR-based clonality studies for early diagnosis of lymphoproliferative disorders', new and standardized, DNA-based PCR approaches were established for detection of immunoglobulin (Ig) and TCR gene rearrangements. 23 The TCRB PCR approach was designed as a multiplex PCR for detection of complete VbJb and incomplete Db-Jb rearrangements. With 23 familyspecific Vb primers (designed to mainly recognize functional Vb gene segments), two specific Db primers and 13 specific Jb primers theoretically most complete Vb-Jb and all incomplete Db-Jb gene rearrangements can be detected with the three BIOMED-2 multiplex tubes. 23 During the last decade, ample experience with the PCR analysis of TCRG and TCRD rearrangements has been obtained, which appeared very helpful in the design and standardization of the BIOMED-2 PCR assays for these two loci. As no reliable PCR method pre-existed for the TCRB genes, PCR results obtained with the newly developed method had to be compared to classical SB analysis. 4 Within Work Package 1 of the BIOMED-2 Concerted Action, only a limited number of T-cell malignancies were analyzed. Consequently, we initiated a more detailed validation study of the new TCRB multiplex PCR by direct comparison of the frequency of PCR-detected complete and incomplete TCRB rearrangements to the frequency of SBdetected rearrangements in immature (ALL) and mature T-cell malignancies.
Material and methods

Samples
Peripheral blood (PB) or bone marrow (BM) samples were selected from 66 patients with T-ALL (31 CD3 negative, 20 TCRab þ , 15 TCRgd þ ) and 36 mature TCRab þ malignancies, including 20 Tcell large granular lymphocyte leukemia (T-LGL), 11 T-cell prolymphocytic leukemia (T-PLL), three mycosis fungoides/Sezary's syndrome and two T-cell lymphoma cases. All samples had been analyzed previously by SB analysis. 4 DNA for PCR analysis had been extracted as previously described and stored at À801C. 4 Control samples included DNA samples of patients with welldefined clonal TCRB rearrangements and polyclonal DNA derived from MNC pooled from five healthy donors.
SB analysis
All TCRB SB data have been published previously by Langerak et al. 4 Seven TCRB probes were used for detection of TCRB rearrangements: TCRBD1U, TCRBD1, TCRBJ1, TCRBD2U, TCRBD2, TCRBJ2, TCRBC (DakoCytomation, Carpinteria, CA, USA); for sequence and position of these probes see Langerak et al. 4 Using the combined information of this set of SB probes, incomplete Db-Jb rearrangements, being defined via upstream Db (TCRBD1U, TCRBD2U) and downstream Jb (TCRBJ1, TCRBJ2) probes, can be reliably identified. Complete Vb-Jb rearrangements can be identified with a considerable degree of reliability, assuming that a rearranged band with the TCRBJ1 or TCRBJ2 probe, with concomitant deletions upon TCRBD1U/ TCRBD1 and/or TCRBD2U/TCRBD2 hybridization reflects a VbJb rearrangement. Consequently, identification of complete TCRB rearrangements with Jb probes is somewhat less reliable than identification of Db-Jb rearrangements with a combination of both Db and Jb probes. Therefore, it cannot be excluded that some SB-assumed Vb-Jb rearrangements in fact represent atypical TCRB rearrangements. 4 
PCR
PCR was performed according to the TCRB PCR protocol of the BIOMED-2 Concerted Action. 23 In short, a multiplex PCR assay with 23 consensus Vb, 2 specific Db and 13 specific Jb primers was applied to identify clonal TCRB rearrangements. Reaction conditions and cycling conditions were used according to the standardized BIOMED-2 TCRB multipex PCR protocol. 23 In short, tubes A and B required 2 U AmpliTaq Gold polymerase (Applied Biosystems, Foster City, CA, USA) and 3 mM MgCl 2 , whereas in tube C 1 U AmpliTaq Gold polymerase and 1.5 mM MgCl 2 were used. 23 PCR was performed on an ABI 9600 thermal cycler (Applied Biosystems) for 35 cycles with a denaturation temperature of 941C for 60 s, annealing at 601C for 60 s and extension at 721C for 60 s (initial denaturation and final extension were extended to 10 and 30 min, respectively). 23 The 13 Jb primers were labeled at their 5 0 end with 6 0 FAM (6-carboxyfluorescein, Applied Biosystems) for automated fluorescent fragment analysis (GeneScanning) of the PCR product. 23 Each PCR product was analyzed for clonality by GeneScanning as well as by heteroduplex analysis, as described in the BIOMED-2 report. 23 
GeneScanning of PCR products
Reaction products were analysed with the GeneScanning software by exact size determination and quantitative measurement of fluorescence intensity after electrophoresis on a highresolution polyacrylamide gel on an ABI PRISM 377 sequencer (Applied Biosystems). For exact protocol, see manufacturer's instructions and the BIOMED-2 report. 23 
Heteroduplex analysis
For heteroduplex analysis, PCR products were denatured for 5 min at 941C and renaturated for 60 min at 41C run to induce duplex formation. 23, 24 Subsequently, hetero-and homoduplexes were separated on 6% nondenaturing polyacrylamide gels and/ Figure 1 Schematic diagram of the structure of the human TCRB locus. One allele with the two consecutive Db-Jb clusters is shown. Two independent TCRB rearrangements can be detected on one allele when an incomplete Db1-Jb1 or complete Vb-Db 1 -Jb 1 rearrangement in the b1 region coincides with an incomplete Db2-Jb2 rearrangement in the b2 region. Rearrangement of a Vb segment to a Db2-Jb2 or Db1-Jb2 coupling results in deletion of the complete Jb1-Cb1 region.
TCRB PCR validation in T-cell malignancies J Droese et al or on commercially available polyacrylamide gels (GeneGel Excel Kit) in a GenePhor electrophoresis unit (Amersham Biosciences, Buckinghamshire, UK). Products were visualized using EtBr or by silver staining (DNA silver stain kit) in a Hoefer automated gel stainer (Amersham Biosciences).
Results and discussion
Detection of TCRB rearrangements is an important tool for clonality diagnostics in patients with suspect T-cell lymphoproliferations as well as for identification of PCR targets in MRD studies. In the past, SB analysis has been the most reliable technique for detection of clonal TCRB rearrangements.
Recently, a new DNA-based multiplex TCRB PCR method has been developed within the BIOMED-2 Concerted Action BMH4-CT98-3936. 23 Comparison of PCR data with SB data of a limited series of T-cell malignancies was an initial step in the validation process during Work Package 1 of the BIOMED-2 Concerted Action. The aim of the present study was the further validation of the BIOMED-2 TCRB PCR protocol 23 using our earlier generated SB data of a large series of 102 T-cell malignancies: 36 mature TCRab þ T-cell malignancies, 31 CD3 negative T-ALL, 15 TCRgd þ T-ALL and 20 TCRab þ T-ALL. 4 Additionally, more information about the frequency of complete and incomplete TCRB rearrangements in mature TCRab þ T-cell malignancies and T-ALL was obtained. The specific structure of the TCRB locus with the Db-Jb-Cb1 and Db-Jb-Cb2 clusters leads to the possibility of two rearrangements per allele, and a maximum number of four detectable TCRB rearrangements per sample (see Figure 1 ). To achieve a reliable PCR-SB comparison of single samples, we therefore decided to establish a scoring system by counting four possible loci for rearrangements on the two alleles in every sample. Unfortunately, due to technical limitations in the PCR protocol, it was impossible to design distinct multiplex tubes with Jb 1 and Jb 2 primers separated, whereas differentially labeled Jb1 and Jb2 primers were tested only in a late stage of the BIOMED-2 Concerted Action. 23 Hence, deduction of the involved Jb region from the PCR data was limited. For evaluation of the PCR results, three categories were applied: detection of a complete Vb-Jb rearrangement, detection of an incomplete Db-Jb rearrangement, and no detectable PCR product. The first two categories could directly be correlated to SB results; the classification of no detectable PCR product may reflect various SB results: germline configuration, deletion of the locus or rarely occurring atypical rearrangements not detectable by PCR (Tables 1 and 2 ). As described by Langerak et al, 4 SB analysis for example also allows to detect the rare VbDb and Db-Db rearrangements. Scoring was performed by comparing SB information from all four loci with the PCR results so that four results were counted for every sample. The only exception was a sample from a T-LGL patient (96-019), which was proven to be biclonal and therefore counted double. 25 
TCRB gene rearrangement frequencies detected by PCR and SB
In 91% (179/204 plus 197/208 is 374/412) of all analyzed loci, a concordant result between PCR and SB could be found (Table 1) . Direct comparison of PCR and SB data showed that 88% of all SB-defined rearrangements have also been found by TCRB PCR and that 95% concordance of SB data and PCR results was found in those loci where no PCR product could be expected from the SB results (Table 1) . Similarly high proportions of 86 and 98%, respectively, were found in the general testing phase of WorkPackage 1 of the BIOMED-2 study. 23 According to both PCR and SB, 28% (116/412) of all loci contained a Vb-Jb rearrangement and 15% (63/412) contained an incomplete DbJb rearrangement. For 48% (197/412) of the loci, no PCR product or PCR-detectable SB result was found.
Discrepancies between PCR-and SB-based analysis of TCRB gene rearrangements
Discrepancies between PCR and SB results were found in a total of 9% (36/412) of the loci (Table 2 ). These findings either comprised the inability to detect a SB-defined rearrangement by PCR (25/412 loci (6%)) or the PCR detection of an additional rearrangement, not detected by SB (11/412 loci (3%): six extra Vb-Jb and five extra Db-Jb). Of the 25 missed rearrangements, 18 concerned complete Vb-Jb and seven incomplete Db-Jb rearrangements. In a single T-ALL case, the failure of PCR detection of one particular rearrangement lead to complete loss of information for the TCRB gene.
Failure to detect TCRB rearrangements by PCR can have various reasons: (1) atypical rearrangements, not detectable with the BIOMED-2 TCRB PCR primers; 4, 26 (2) rearrangement of a The total number of rearrangements is based on the assumption that theoretically four TCRB gene rearrangements can occur in one sample, because both TCRB alleles contain a Db-Jb-Cb1 and a Db-Jb-Cb2 region. Consequently, the number of samples is multiplied by four to obtain the number of theoretical rearrangements.
b Proportion of samples with PCR-detectable TCRB rearrangements per SB-detected TCRB rearrangements.
c Samples in which no TCRB PCR product was detected, whereas in SB analysis a germline configuration, deletion of (part of) the TCRB locus or a non-PCR-detectable rearrangement (other) was seen.
nonfunctional Vb gene segment, not recognized by the BIOMED-2 primers; (3) sequence variations (eg polymorphisms) of the rearranged gene segments leading to the impossibility of the PCR primers to anneal appropriately; 8 (4) lack of PCR sensitivity for particular Vb-Jb rearrangements, because Vb primers were tested with polyclonal samples and not in all cases with predefined clonal samples involving the specific Vb segment; 23 (5) lack of one of two Vb-Jb rearrangements due to preferential amplification of one rearrangement. Detection of additional rearrangements in PCR can be explained by (1) inability to detect a rearrangement by SB, due to for example, comigration with the germline band or another rearranged band; (2) an additional smaller clone not detectable by SB, due to the lesser sensitivity of SB; (3) selective amplification of a pseudoclone, although so far this has mainly been found in Bcell proliferations. 23, 27 In an attempt to further explain the discrepant results on Vb-Jb rearrangements in our samples, we could exploit available data from Vb-Cb RT-PCR analysis in two TCRab þ T-ALL and 10 mature TCRab þ T-cell malignancies. 25 Together, these 12 samples represented 7/18 missed Vb-Jb rearrangements in multiplex PCR and 6/6 extra Vb-Jb multiplex PCR products (Table 3 ). By comparing earlier described RT-PCR-derived VbCb sequences 25 with sequences of all detected multiplex Vb-Jb PCR products in these samples, we found identical results between these two PCR methods in six cases, thereby confirming the multiplex PCR data (Table 3) . Interestingly, five out of the six extra PCR products in four cases (T015, 91-004, 93-067, 95-082) concerned a rearrangement to Jb1.1; due to the position of the HindIII restriction site downstream of Jb1.1, rearrangements involving this segment can only be detected using EcoRI digests, which is probably why they are more easily missed in SB analysis. The sixth extra Vb-Jb product concerned a rearrangement to Jb2.1. In the two other cases (T069, 95-123), in which the results from the multiplex PCR and the RT-PCR were identical, the SB-assumed Vb-Jb2 rearrangements most probably concerned atypical rearrangements (Table 3) . Another finding in this evaluation was that in four samples (96-019, 96-020, 96-042, 96-154), one of the two sequences (as known from the Vb-Cb RT-PCR products) was missed in the Vb-Jb multiplex PCR; close examination showed that competition of Vb-Jb targets probably played a role, since in all, except sample 96-154, the two products should have been amplified in the same multiplex tube (Table 3) . Finally, one case remained unexplained through lack of reliable sequence data from the multiplex PCR products.
Interpretation problems of PCR reactions cannot always be overcome as they are caused by an inherent disadvantage of the PCR technology: its extreme sensitivity leading to false-positive results in case of subclone formation. To verify a doubtful clonal result multifold PCR and subsequent heteroduplex analysis of the mixed PCR products, or sequencing of the PCR products should therefore be considered. Also, additional information regarding the clinical, morphological and immunohistochemical status of the tested sample should always be included for final interpretation.
Comparison between GeneScanning and heteroduplex analysis
As described in the original BIOMED-2 TCRB PCR protocol, 23 GeneScanning as well as heteroduplex analysis can be used to analyze the clonality of the PCR products. In our current series, no clear discrepancies in the interpretation of GeneScanning and heteroduplex results appeared.
In only 2/102 (2%) cases (both CD3 negative T-ALL), heteroduplex analysis revealed a single monoclonal band, whereas in GeneScanning an additional, but weak, monoclonal peak was detected. However, as the second peak in GeneScanning was so weak, the overall result was scored as monoallelic. In SB, biallelic rearrangements were found. Both discrepancies concerned tube A and might have been caused by preferential amplification of one Vb-Jb rearrangement over the other.
Overall, less discrepancies were found in this series compared to the general testing phase of Work Package 1 of the BIOMED-2 study, which is probably due to the selection of T-cell malignancies with a definite tumor load of at least 80% in the current series, 4 whereas in the general testing phase of the BIOMED-2 project also many B-cell malignancies and samples with a lower tumor load were included. 23 Nevertheless, the combined use of heteroduplex analysis and GeneScanning is still recommended for diagnostic application of the new TCRB PCR method. 23 On the one hand, in heteroduplex analysis the polyclonal background is separated from the clonal signal thus facilitating detection, but on the a The total number of rearrangements is based on the assumption that theoretically four TCRB gene rearrangements can occur in one sample, because both TCRB alleles contain a Db-Jb-Cb1 and a Db-Jb-Cb2 region. Consequently, the number of samples is multiplied by four to obtain the number of theoretical rearrangements.
b Proportion of samples with discrepant PCR results per SB-positive results. c Samples in which a TCRB PCR product was detected, whereas in SB analysis a germline configuration, deletion of (part of) the TCRB locus or a non-PCR-detectable rearrangement (other) was seen. Table 3 Detailed evaluation of discrepant results on Vb-Jb detection in a series of TCRab + T-ALL and mature TCRab + T-cell malignancies 
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Leukemia other hand, the sensitivity of heteroduplex analysis is somewhat lower than for GeneScanning. 23, 24 Another advantage of GeneScanning is the exact size determination that allows to distinguish PCR products outside the expected size range and to use GeneScanning for qualitative follow-up. 14, 18, 23, 28 Frequency of TCRB rearrangements per disease category
In 97% (99/102) of the total group of mature TCRab þ T-cell malignancies and T-ALL, at least one clonal TCRB gene rearrangement was found by PCR: 100% in mature TCRab þ malignancies, 94% in CD3-negative T-ALL, 93% in TCRgd þ T-ALL, 100% in TCRab þ T-ALL, which is in line with previously published data ( Table 4 bottom) . 3, 4, 14, 15, 29, 30 Of the remaining three cases, two did not show a TCRB configuration in SB analysis that should lead to PCR-detectable TCRB rearrangements: one TCRgd þ T-ALL case was germline on both alleles, whereas one CD3-negative T-ALL case showed two incomplete Vb-Db rearrangements in SB. In the third case (CD3 negative T-ALL), SB-defined Vb-Jb and Db-Jb rearrangements failed to be detected by PCR. Consequently, in 99 of the 100 samples (99%) that showed TCRB rearrangements in SB, at least one TCRB rearrangement, either complete or incomplete, was found with the BIOMED-2 TCRB multiplex PCR.
In the category of mature TCRab þ T-cell malignancies, 100% (36/36) of cases had at least one complete Vb-Jb rearrangement, whereas in 64% (23/36) of cases an incomplete Db-Jb rearrangement was detected. In the total group of T-ALL, in 83% (55/66) of cases a complete Vb-Jb rearrangement was present, compared to 50% (33/66) of cases with incomplete DbJb rearrangements (Table 4 top). Further division of T-ALL categories revealed differences between the subtypes: similar to mature TCRab þ T-cell malignancies, TCRab þ T-ALL and CD3-negative T-ALL also have a high frequency of complete Vb-Jb rearrangements and a lower frequency of incomplete Db-Jb rearrangements (100 and 45% for TCRab þ T-ALL, and 90 and 41% for CD3-negative T-ALL, respectively). In contrast, in TCRgd þ T-ALL the frequency of incomplete Db-Jb rearrangements (73%) was essentially higher than the frequency of complete Vb-Jb rearrangements (46%). TCRB rearrangement is initiated very early during T-cell differentiation. As a first step, a Db segment is combined with a Jb gene segment followed by joining of a Vb segment to the DbJb complex. This might explain the high frequency of complete Vb-Jb rearrangements in cells with TCRab expression compared to the higher frequency of incomplete Db-Jb rearrangements in TCRgd þ T-ALL, which are thought to be derived from a separate gd differentiation pathway, split off very early during T-cell development but after the onset of the TCRB gene rearrangement process. 1, 3 This is line with a recent study by Asnafi et al 31 who consider immature CD3-negative T-ALL with only Db-Jb rearrangements as belonging to the gd lineage, whereas the presence of complete Vb-Jb rearrangements would predispose them to the ab lineage. Again in line with the data from Asnafi et al 31 apparently a large fraction of CD3-negative T-ALL are associated with the ab lineage, since they have a TCRab-like TCRB gene rearrangement pattern. The differences in TCRB gene rearrangement patterns between gd lineage and ab lineage T-cell malignancies become even more prominent by the frequencies of cases with two or more rearranged TCRB loci: 33% in TCRgd þ T-ALL vs 65, 80 and 68% in CD3-negative T-ALL, TCRab þ T-ALL and mature TCRab þ T-cell malignancies, respectively (Table 4 bottom) .
Irrespective of the differences in TCRB rearrangement patterns between categories, the overall detection rate of 97% (99/102) makes the TCRB rearrangement an attractive marker for followup of MRD, especially in T-ALL. 14, 18 Strategical implications for clonality and MRD analysis of TCRB rearrangements
In the subanalysis of complete Vb-Jb rearrangements, a predominance of tube A-positive PCR reactions was found: 63% (57/91) of cases with a Vb-Jb rearrangement were positive in tube A (Jb1 or Jb2) and 54% (49/91) were positive in tube B Table 4 TCRB gene rearrangement patterns in 102 T-cell malignancies as detected by PCR analysis CCI  3%  100%  9%  83%  7%  90%  13%  46%  10%  100%  CII  22%  I:  8%  I:  3%  I:  0%  I:  20%  I:  CCII  0%  64% 0%  50% 0%  41% 0%  73% 0%  45%  I  0%  12%  3%  47%  0%  II  0%  0%  0%  0% (only Jb2). A total of 16 cases were positive in both tube A and tube B (data not shown). Knowledge about unequal distribution of complete Vb-Jb and incomplete Db-Jb rearrangements between the disease categories could be applied for a strategic use of the PCR tubes in clonality assessment and identification of clonal markers for MRD studies. For clonality assessment in suspect mature T-cell proliferations or for identification of an MRD-PCR target in CD3-negative or TCRab þ T-ALL, detection of a complete Vb-Jb rearrangement is more likely. Therefore, analysis should be started with tubes A and B (a predominance for positivity of tube A was found in this series); for TCRgd þ T-ALL, tube C might preferentially be applied.
Conclusions
In summary, our results show a good concordance of PCR results generated with the multiplex TCRB PCR approach developed by the BIOMED-2 study group compared to SB data on the same series of mature TCRab þ T-cell malignancies and T-ALL. In the vast majority of the cases, the combined use of GeneScanning and heteroduplex analysis for clonality assessment of the PCR products leads to conclusive interpretations. These data underline the reliability of the new BIOMED-2 TCRB PCR method and its applicability in clonality diagnostics of (T cell) lymphoproliferative disorders as well as for PCRbased MRD studies.
